Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -522.97% is 36% below its 4-year average of -384.39%, around the middle of its 4-year range (-1454.02%–110.71%).
7.97% above its 12-month average of -568.29%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -225.12%.
NET PROFIT MARGIN
-522.97%
NET PROFIT MARGIN AVG TTM
-568.29%
NET PROFIT MARGIN AVG 3Y
-304.15%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+7.97%
CURRENT VS 3Y AVG
-71.94%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-149320.00%
vs the sector median at left
PMGC Holdings Inc.
Market Cap
$1.49M
Net Profit Margin
-522.97%
TTM Avg
-568.29%
3Y Avg
-304.15%
5Y Avg
N/A
Market Cap
$1.47M
Net Profit Margin
-51.26%
TTM Avg
-32.02%
3Y Avg
-93.24%
5Y Avg
-164.46%
Market Cap
$1.46M
Net Profit Margin
-490.33%
TTM Avg
-239.03%
3Y Avg
-377.20%
5Y Avg
-368.58%
Market Cap
$1.52M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.42M
Net Profit Margin
-70.18%
TTM Avg
-240.09%
3Y Avg
-517.75%
5Y Avg
-505.95%
Market Cap
$1.39M
Net Profit Margin
-14220.12%
TTM Avg
-19831.38%
3Y Avg
-10446.98%
5Y Avg
-7103.54%
Market Cap
$1.34M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.64M
Net Profit Margin
-8269.53%
TTM Avg
-5978.05%
3Y Avg
-5627.38%
5Y Avg
-2838.61%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | $1.49M | -522.97% | -568.29% | -304.15% | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.47M | -51.26% | -32.02% | -93.24% | -164.46% |
| Curis, Inc. (CRIS)vs › | $1.46M | -490.33% | -239.03% | -377.20% | -368.58% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -70.18% | -240.09% | -517.75% | -505.95% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.39M | -14220.12% | -19831.38% | -10446.98% | -7103.54% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -8269.53% | -5978.05% | -5627.38% | -2838.61% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.32M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-1250.1%
Net Profit Margin
-523.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -225.12% |
| 2026-03-31 | -728.34% |
| 2025-12-31 | -980.71% |
| 2025-09-30 | -907.27% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 110.71% |
| 2024-09-30 | -284.61% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -227.36% |
| 2023-12-31 | -165.75% |
| 2023-09-30 | -141.18% |
| 2023-06-30 | -404.34% |
| 2023-03-31 | -756.68% |
| 2022-12-31 | -469.88% |
| 2022-09-30 | -115.50% |
| 2022-06-30 | -168.97% |
| 2022-03-31 | -1454.02% |
